Group 1 - The company announced a change in the signing auditors for the fiscal year 2025 from Fan Guiming and Yang Yun to Yang Yun and Deng Xiaowei [2] - The change is due to internal adjustments within Zhongshun Zhonghuan and will not affect the annual report or internal control audit [2]

中审众环为公司 2025 年度财务和内部控制审计机构，原委派范桂铭（项目 合伙人）、杨云（签字注册会计师）为公司提供审计服务。鉴于中审众环内部工 作调整，原项目合伙人范桂铭不再担任公司 2025 年度审计项目签字注册会计师， 原签字注册会计师杨云调整为项目合伙人，新增委派邓晓微为公司签字注册会计 师。本次变更后的签字注册会计师为杨云和邓晓微。 二、本次变更人员的基本信息 （一）人员信息 签字注册会计师：邓晓微，2017 年成为中国注册会计师，2017 年起开始从 事上市公司审计，2024 年起开始在中审众环执业，2024 年度开始为公司提供审 计服务。最近 3 年签署上市公司审计报告 0 家。 证券代码：600654 证券简称：中安科 公告编号：2026-005 中安科股份有限公司 关于变更签字会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中安科股份有限公司（以下简称"公司"）分别于 2025 年 4 月 17 日、2025 年 5 月 9 日召开第十一届董事会第二十七次会议、2024 年年度股东大会，审议 通 ...

Core Viewpoint - The company has implemented a stock option and restricted stock incentive plan, with significant participation and completion of stock transfers in the second exercise period, indicating strong engagement from the incentive recipients [2][11]. Summary by Sections Incentive Plan Overview - The total number of stock options exercised in the second exercise period is 1,170,480 shares, representing 60.96% of the total options available for exercise [2]. - As of the end of the fourth quarter of 2025, a cumulative total of 1,883,021 shares have been exercised and registered, accounting for 98.07% of the total options available for the second exercise period [2]. Decision-Making Process and Disclosure - On March 17, 2023, the company’s board approved the incentive plan and related proposals, with independent directors providing clear consent [3]. - The company publicly disclosed the names and positions of the incentive recipients from March 18 to March 27, 2023, with no objections received during this period [3]. Stock Option Grant and Registration - On April 3, 2023, the company held a shareholder meeting to approve the grant of stock options and restricted stocks to 148 eligible recipients, totaling 65.5 million options and stocks [5]. - The stock options were registered on June 1, 2023, with 10.05 million options registered for 42 individuals [5]. Stock Buyback and Cancellation - On December 1, 2023, the company approved the buyback and cancellation of 1,130,000 restricted stocks from two former incentive recipients [6]. - The company continued to manage stock buybacks and cancellations throughout 2024, including the cancellation of options and stocks from individuals who left the company [9][12]. Exercise Results and Financial Impact - In the fourth quarter of 2024, 2,479,460 shares were exercised, representing 99.23% of the first exercise period options [11]. - The company reported that the exercise of stock options and the issuance of new shares would not have a significant impact on its financial status or operational results [18]. Fund Utilization - The funds raised from the exercise of stock options in the fourth quarter of 2025 amounted to 2,340,960 RMB, which will be used to supplement the company's working capital [17].

Core Viewpoint - The announcement details the results of the stock option and restricted stock incentive plan for the fourth quarter of 2025, highlighting the number of shares exercised and the overall participation in the plan. Group 1: Stock Option Exercise Results - In the fourth quarter of 2025, a total of 1,170,480 shares were exercised under the second exercise period of the incentive plan, accounting for 60.96% of the total options available for exercise during this period [2] - By the end of the fourth quarter of 2025, the cumulative number of shares exercised and registered under the second exercise period reached 1,883,021 shares, representing 98.07% of the total options available for this period [2] - The shares obtained through the exercise will be listed for trading on the second trading day after the exercise date (T+2) [2] Group 2: Decision-Making Process and Disclosure - The decision-making process for the incentive plan was approved by the board of directors on March 17, 2023, with independent directors providing their consent and legal opinions being issued [3][4] - The company publicly disclosed the names and positions of the incentive plan participants from March 18 to March 27, 2023, with no objections received during the public notice period [3] - The first grant of stock options and restricted stocks was approved on April 3, 2023, with a total of 65.5 million stock options and restricted stocks granted [4][5] Group 3: Stock Option and Restricted Stock Details - The stock options granted were priced at 2.00 CNY per share, while the restricted stocks were priced at 1.25 CNY per share [5] - The registration of stock options and restricted stocks was completed on June 1 and June 19, 2023, respectively, with 10.05 million stock options and 53.32 million restricted stocks registered [5][6] - The company has conducted buybacks of restricted stocks for individuals who have left the company, with specific numbers detailed in subsequent announcements [6][9] Group 4: Financial Impact and Fund Utilization - The funds raised from the exercise of stock options in the fourth quarter of 2025 amounted to 2,340,960 CNY, which will be used to supplement the company's working capital [16] - The exercise of stock options is not expected to have a significant impact on the company's financial status or operating results [17]

Group 1: Transaction Overview - Company has approved the sale of 100% equity in its wholly-owned subsidiary, Guardforce Investment Holdings Pty Ltd, which includes 34 companies under the "Australian Security Group," to Gilmore Investment Holdings Limited for a cash consideration of 16.8 million AUD, based on an assessed value of 16.6428 million AUD as of July 31, 2025 [2] - The buyer has completed the first payment of 8 million AUD as per the share purchase agreement, with the completion of the share transfer expected to occur within 15 working days after the payment of the deposit [3] Group 2: Progress of the Transaction - Due to local holidays in Australia, the share transfer procedures have not yet been completed, leading to a postponement of the transfer date [3] - The company will expedite the share transfer process and continue to monitor the progress of the sale, ensuring timely information disclosure [3] Group 3: Board Secretary Appointment - Company has appointed Mr. Zhu Ming as the board secretary, with his term lasting until the end of the current board's term [5] - Mr. Zhu possesses the necessary qualifications and has obtained the Board Secretary Qualification Certificate issued by the Shanghai Stock Exchange [5][7] Group 4: Board Meeting Details - The company's eighth board meeting of the twelfth session was held on December 31, 2025, via telecommunication, with all nine directors present [9] - The meeting approved the appointment of the board secretary with a unanimous vote of 9 in favor [10]

证券代码：600654 证券简称：中安科 公告编号：2026-004 中安科股份有限公司 关于 2023 年股票期权与限制性股票激励计划 2025 年 第四季度自主行权结果暨股份变动公告 一、本激励计划已履行的决策程序及相关信息披露 1、2023 年 3 月 17 日，公司召开第十一届董事会第六次会议审议通过了《关 于<公司 2023 年股票期权与限制性股票激励计划（草案）>及其摘要的议案》《关 于<公司 2023 年股票期权与限制性股票激励计划实施考核管理办法>的议案》《关 于提请股东大会授权董事会办理公司股权激励计划有关事项的议案》，公司独立 董事对上述议案发表了明确同意的独立意见，律师出具了相应的法律意见书。 同日，公司召开了第十一届监事会第五次会议审议通过了《关于<公司 2023 年股票期权与限制性股票激励计划（草案）>及其摘要的议案》《关于<公司 2023 年股票期权与限制性股票激励计划实施考核管理办法>的议案》。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次行权股票数量：2025 年第四季度 ...

Core Viewpoint - Zhong An Ke's stock price has shown a positive trend with a year-to-date increase of 2.12% and significant growth over the past 60 days, indicating strong market interest and potential for future performance [1]. Financial Performance - For the period from January to September 2025, Zhong An Ke achieved a revenue of 2.365 billion yuan, representing a year-on-year growth of 15.84% [2]. - The net profit attributable to shareholders reached 198 million yuan, marking a substantial increase of 1748.16% compared to the previous year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders increased to 116,900, up by 0.56% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 0.33% to 19,815 shares [2]. Stock Performance and Trading Activity - On January 5, Zhong An Ke's stock price rose by 2.12%, reaching 3.85 yuan per share, with a trading volume of 175 million yuan and a turnover rate of 1.98% [1]. - The stock has seen a net inflow of main funds amounting to 6.75 million yuan, with significant buying activity from large orders [1]. Business Overview - Zhong An Ke, established on December 31, 1991, and listed on December 19, 1990, is based in Wuhan, Hubei Province, and specializes in security system integration, security operation services, and IoT product manufacturing [1]. - The company's revenue composition includes 66.03% from security operation services, 27.76% from smart city system integration, 5.88% from security intelligent product manufacturing, and minor contributions from leasing and other services [1]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited is the seventh largest circulating shareholder, holding 13.9336 million shares, a decrease of 706,100 shares from the previous period [3]. Dividend Information - Since its A-share listing, Zhong An Ke has distributed a total of 351 million yuan in dividends, with no dividends paid in the last three years [3].

一、董事会会议召开情况 证券代码：600654 证券简称：中安科 公告编号：2026-001 中安科股份有限公司 第十二届董事会第八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 具 体 内 容 详 见 公 司 于 2026 年 1 月 1 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的《关于聘任董事会秘书的公告》（公告编号：2026-002）。 表决情况：9 票同意，0 票反对，0 票弃权。 特此公告。 中安科股份有限公司 董事会 二〇二六年一月一日 中安科股份有限公司（以下简称"公司"）第十二届董事会第八次会议于 2025 年 12 月 31 日以通讯表决方式召开。会议通知于 2025 年 12 月 24 日以电话、 电子邮件方式向全体董事发出。本次会议应到董事 9 人，实到董事 9 人。本次会 议由董事长吴博文先生主持，会议的召集、召开及表决程序符合《公司法》和《公 司章程》的规定。 二、董事会会议审议情况 经与会董事表决，会议审议通过如下决议： 审议通过《关于聘任公司 ...

证券代码：600654 证券简称：中安科 公告编号：2026-003 中安科股份有限公司 根据公司全资子公司 Guardforce Investment Holdings Pty Ltd 与买方签署的 《股份购买协议》，买方已在协议约定的期限内完成了首笔 800 万澳元款项的支 付。 根据《股份购买协议》约定："交割应在交割日于双方书面约定的时间和地 点进行，应当在买方根据第 9.2 条约定支付定金后 15 个工作日内完成（交割日 期），最迟不得晚于 2025 年 12 月 31 日。尽管有前述约定，如经双方协商一致， 或非因买方原因无法在前述约定日期前完成交割的，交割日期应相应顺延。"由 于受澳大利亚当地节假日的影响，截至目前，上述股权交割手续尚未完成，本次 交易涉及的股权交割日期相应顺延。 公司将尽快办理股权交割手续，持续关注上述出售全资子公司股权事项的相 关进展情况，并及时履行信息披露义务。公司指定信息披露媒体为《中国证券报》 《上海证券报》及上海证券交易所网站（www.sse.com.cn），公司公开披露的信 息均以在上述指定信息披露媒体刊登的内容为准，敬请广大投资者关注后续公告 并注意投资风险。 特 ...

证券代码：600654 证券简称：中安科 公告编号：2026-002 联系电话：027-87827922 电子邮箱：zqtzb@600654.com 联系地址：湖北省武汉市武昌区华中小龟山金融文化公园五栋 特此公告。 中安科股份有限公司 关于聘任董事会秘书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中安科股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日召开第十二 届董事会第八次会议，审议通过了《关于聘任公司董事会秘书的议案》，经公司 董事会提名委员会审核通过，公司董事会同意聘任朱明先生为公司董事会秘书 （简历附后），任期至第十二届董事会届满之日止。董事长吴博文先生将不再代 行董事会秘书职责。 朱明先生具备担任董事会秘书所需的专业知识，已取得上海证券交易所颁发 的《董事会秘书资格证明》，任职资格符合《公司法》《上海证券交易所股票上市 规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关法 律法规的规定。 朱明先生联系方式如下： 截至目前，朱明先生未持有公司股份，与公司董事、高级 ...